Compare GuardianTM Connect CGM System to the Abbott Freestyle Libre System
GuardianTM Connect CGM System*
Abbott Freestyle Libre System
Predictive High Glucose Alerts
SystemScan Required for Alert
Low Glucose Detection Alert
Sensor Glucose Alerts
Sugar.IQTM Intelligent Assistant App Diabetes assistant for data-backed insights
Care Partner Monitoring
StartRightSM Program Personalized Onboarding & Support
FDA Approved Sensor Life
Up to 7 days
No Dedicated Monitor Required at Purchase
Get More Than Numbers, Get Answers
Diabetes management with insulin injections can be better with the right glucose monitoring system. GuardianTM Connect Smart CGM gives you continuous coverage and predictive alerts that no other glucose monitor can. And with the exclusive Sugar.IQTM assistant, you can stay ahead with personal diabetes insights.
GET STARTED TODAY
“Getting an alert before I go low helps me to not experience that nervous/weak feeling of already being low. It's like nothing I’ve experienced from other CGM systems.”***
– Brett, Living with Type 1 Diabetes
Take The Next Step Towards Smart CGM
Order Today 888-882-8602
To get updates and to have a diabetes therapy consultant contact you, fill out the form below.
*The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained using a home blood glucose meter and not on values provided by the system.
**Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to Sugar.IQTM insights that can inform users of clinically relevant glucose patterns.
***Brett was compensated for spending the day with us and allowing us to photograph him and his children, he is also a family member of a Medtronic employee. Thoughts and experiences shared are his own.
By submitting this form, you are granting Medtronic MiniMed, Inc. ("Medtronic") permission to add your contact information to its database for sending you additional information and communications related to Medtronic products and therapies. You may revoke this permission at any time by e-mailing firstname.lastname@example.org or by sending a request in writing to: Medtronic MiniMed, Inc. c/o Customer Support, 18000 Devonshire Street, Northridge, CA 91325-1219
Important Safety Information
The GuardianTM Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings in place for accurate operation. A non-functioning mobile device or incorrect settings may prevent the app from issuing alerts. Missing alerts may result in undetected low and high glucose levels. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and www.medtronicdiabetes.com/importantsafetyinformation.
AUTHORIZATION FOR USE OF PROTECTED HEALTH INFORMATION
You authorize Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes or its subsidiaries, contractors or representatives to use your personal information, including but not limited to your contact information and health information, for marketing purposes and to share that information with Medtronic representatives and contractors. Information you may receive includes, but is not limited to: (a) Medtronic Diabetes products, therapies or services; (b) marketing and promotional offers; (c) inquiries about your experience with Medtronic Diabetes products, therapies and services; and/or (d) suggestions for how Medtronic Diabetes can enhance its customer support.
This authorization will expire three (3) years from the later of the date you submit this authorization online; or (ii) the last date products or services were received from Medtronic, but may expire sooner if you revoke it by following the instructions below.
You have the right to revoke this authorization at any time by (i) e-mailing email@example.com; or (ii) signing into your myHome profile and updating my communication preferences at www.diabetes.shop/myhome. A revocation will not affect actions Medtronic Diabetes has already taken based on this authorization. Information disclosed pursuant to this authorization may be re-disclosed by the recipient of the information and may no longer be protected by the federal privacy standards.
You have the right to refuse to sign this authorization. Refusal to sign will not affect your treatment or health insurance eligibility or benefits.
Questions? Contact our Customer Service Center at 800-646-4633, or by email at firstname.lastname@example.org.
CONSENT FOR RECEIPT OF PHONE COMMUNICATIONS
You consent to receiving phone calls, including pre-recorded and auto-dialed communications, at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) e-mailing email@example.com; or (ii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).
CONSENT FOR RECEIPT OF TEXT COMMUNICATIONS
You consent to receiving text messages at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) texting "STOP" in return to a text; (ii) sending an email to firstname.lastname@example.org; or (iii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).